RE: Just got off the phone with EpitopixBeech. Thanks for the interesting update. That's a gem. I hope it does translate to a "one-horse race" as you mentioned.
Did you ask them why they don't plan for a second trial?
How do they plan to satisfy the USDA for the approval for Epitopix then? No supporting data, no approval.
Are they giving up? Is that due to Econiche being too superior a competitor? Or perhaps they don't see a realistic future for the vaccination adoption?
Last but not least, how reliable is your source?